Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 14.86% is 78% below its 5-year average of 67.31%, near the low end of its 5-year range (3.61%–357.90%).
As of the fiscal period ended Wednesday, December 31, 2025. 59.63% below its 12-month average of 36.82%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 14.86%.
DEBT TO ASSETS RATIO
14.86%
DEBT TO ASSETS RATIO AVG TTM
36.82%
DEBT TO ASSETS RATIO AVG 3Y
64.91%
DEBT TO ASSETS RATIO AVG 5Y
67.31%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-59.63%
CURRENT VS 3Y AVG
-77.10%
CURRENT VS 5Y AVG
-77.92%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+16415.47%
vs the sector median at left
NewGenIvf Group Limited
Market Cap
$6001.00
Debt to Assets Ratio
14.86%
TTM Avg
36.82%
3Y Avg
64.91%
5Y Avg
67.31%
Market Cap
$30509.00
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$72519.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97282.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108688.00
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$380715.00
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewGenIvf Group Limited (NIVF) | $6001.00 | 14.86% | 36.82% | 64.91% | 67.31% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30509.00 | 0.01% | N/A | N/A | N/A |
| Zhongchao Inc. (ZCMD)vs › | $30910.00 | 0.00% | N/A | N/A | N/A |
| Akanda Corp. (AKAN)vs › | $61463.00 | 2.89% | N/A | N/A | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $72519.00 | 0.00% | N/A | N/A | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $97282.00 | 0.00% | N/A | N/A | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108688.00 | 0.33% | N/A | N/A | N/A |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | 0.05% | N/A | N/A | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | 0.05% | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | 0.18% | N/A | N/A | N/A |
Debt/Assets
14.9%
Debt/Equity
0.18
Current Ratio
3.12
Interest Coverage
-17.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2025-12-31 | 14.86% |
| 2025-09-30 | 15.48% |
| 2024-12-31 | 80.12% |
| 2024-09-30 | 357.90% |
| 2023-12-31 | 7.41% |
| 2023-09-30 | 3.61% |
| 2023-06-30 | 24.36% |
| 2022-12-31 | 15.56% |
| 2021-09-30 | 80.23% |
| 2021-05-31 | 73.53% |
